Genomic Selection Platform Market Report 2026

Genomic Selection Platform Market Overview

• Genomic Selection Platform market size has reached to $2.27 billion in 2025 • Expected to grow to $4.96 billion in 2030 at a compound annual growth rate (CAGR) of 16.8% • Growth Driver: Increasing Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomics And Tailored Treatment Strategies • Market Trend: Meta Strengthens VR Haptics With Lofelt Acquisition • North America was the largest region in 2025.

What Is Covered Under Genomic Selection Platform Market?

A genomic selection platform is a technology-driven system that uses genome-wide genetic information to predict the performance or breeding value of plants, animals, or microorganisms. It helps to accelerate selective breeding by identifying individuals with the most desirable traits early, reducing the need for lengthy traditional evaluation cycles. It combines high-throughput genotyping, statistical models, and predictive algorithms to guide informed selection decisions efficiently. The main components of genomic selection platform are software, hardware, and services. refers to specialized computational tools and applications designed to analyze large-scale genomic data to support genomic selection in breeding programs. It can be deployed either on-premises or cloud-based modes, and is used in applications such as plant breeding, animal breeding, human genomics, and others. The key end-users include research institutes, biotechnology companies, agricultural organizations, and others.

What Is The Genomic Selection Platform Market Growth Forecast?

The genomic selection platform market size is expected to see rapid growth in the next few years. It will grow to $4.96 billion in 2030 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to increasing adoption of genomic selection in agriculture, rising use of predictive analytics in breeding programs, expansion of sustainable crop and livestock development, growing integration of genomics with precision agriculture, advancement of cloud-native genomic platforms. Major trends in the forecast period include increasing adoption of AI-driven genomic prediction models, rising use of high-throughput genotyping platforms, growing integration of cloud-based breeding analytics, expansion of predictive breeding decision support systems, enhanced focus on trait-based selection accuracy.

Global Genomic Selection Platform Market Segmentation

1) By Component: Software, Hardware, Services 2) By Deployment Mode: On-Premises, Cloud-Based 3) By Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications 4) By End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End-Users Subsegments: 1) By Software: Genomic Data Management Software, Bioinformatics And Statistical Analysis Tools, DNA Or RNA Sequencing Data Processing Software, Genomic Prediction And Modeling Software, Cloud-Based Genomic Platforms, Workflow Automation And Integration Tools 2) By Hardware: Next-Generation Sequencing (NGS) Systems, Polymerase Chain Reaction (PCR) Instruments, Microarray Analyzers, High-Performance Computing (HPC) Systems, Data Storage Servers, Laboratory Automation And Robotics 3) By Services: Sequencing And Genotyping Services, Data Analysis And Interpretation Services, Cloud Hosting And Data Storage Services, Custom Bioinformatics Solutions, Training And Technical Support Services, Consulting And Implementation Services

What Are The Drivers Of The Genomic Selection Platform Market?

The increasing adoption of personalized medicine is expected to propel the growth of the genomic selection platform market going forward. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to an individual’s unique genetic makeup, lifestyle, and environment. The increasing adoption of personalized medicine is primarily due to advancements in genomics, which enable precise identification of genetic variations and tailored treatments for individuals. Genomic selection platforms support personalized medicine by providing precise genomic insights, making them ideal for tailoring treatments to individual patients. They reduce trial-and-error in therapy selection by predicting responses to interventions, improving treatment effectiveness, and improving patient outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the increasing adoption of personalized medicine is driving the growth of the genomic selection platform industry. The increasing crop yields are expected to drive the growth of the genomic selection platform market going forward. Crop yield is the amount of agricultural output (such as grains, fruits, or vegetables) produced per unit of land. Crop yield is rising due to advances in agricultural biotechnology that enhance plant genetics and resilience. Genomic selection platforms enhance crop yields by enabling precise selection of high-performing plant varieties, making them ideal for modern agriculture and breeding programs. They reduce the time and cost of traditional breeding by providing accurate genetic predictions, improving farm productivity, and improving food security. For instance, in May 2025, the Central Statistics Office, an Ireland-based agricultural statistics agency, reported that crops like potato production increased by 46,100 tonnes annually to 368,300 tonnes in 2024. Potato yield rose by 1.0% to 39.6 tonnes per hectare. The area of potatoes was 9,300 hectares in 2024, which was 1,100 hectares, or 13.2%, more than in 2023. Therefore, the increasing crop yields are driving the growth of the genomic selection platform industry.

Key Players In The Global Genomic Selection Platform Market

Major companies operating in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., Enigma Genomics Inc.

Global Genomic Selection Platform Market Trends and Insights

Major companies operating in the genomic selection platform market are focusing on developing innovative solutions, such as targeted sequencing platforms, to improve trait prediction and accelerate breeding programs. Targeted sequencing platforms refer to genomic technologies and systems designed to sequence specific regions of the genome rather than the entire genome. For instance, in October 2024, Element Biosciences Inc., a US-based life sciences technology company, launched Trinity, a breakthrough targeted sequencing platform that streamlines exome capture by integrating traditionally complex steps directly into its AVITI System. The platform eliminates the need for specialized equipment, reduces manual work by up to five hours, and offers a one-hour hybridization option for same-day results, making it ideal for time-sensitive studies. Trinity expands to support custom panels across diverse applications such as oncology, respiratory diseases, and minimal residual disease (MRD). It delivers faster, more cost-effective, and more accessible sequencing, marking the first major advancement in exome capture.

Regional Outlook

North America was the largest region in the genomic selection platform market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genomic Selection Platform Market?

The genomic selection platform market consists of revenues earned by entities by providing services such as genotyping, phenotyping, data analysis and interpretation, predictive modeling, breeding program management, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomic selection platform market also includes sales of genotyping platforms, sequencing platforms, bioinformatics software, data analysis tools, marker-assisted selection tools, DNA extraction kits, and high-throughput genotyping assays. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Genomic Selection Platform Market Report 2026?

The genomic selection platform market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the genomic selection platform industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.